IL-2 production in developing Th1 cells is regulated by heterodimerization of RelA and T-bet and requires T-bet serine residue 508

被引:125
作者
Hwang, ES
Hong, JH
Glimcher, LH [1 ]
机构
[1] Ewha Womans Univ, Div Mol Life Sci, Seoul 121742, South Korea
[2] Ewha Womans Univ, Coll Pharm, Seoul 121742, South Korea
[3] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA
[5] MIT, Dept Biol, Canc Res Ctr, Cambridge, MA 02139 USA
关键词
D O I
10.1084/jem.20051044
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interleukin ( IL)-2 is the predominant cytokine that is produced by naive Th cells in a primary response. It is required for proliferation and differentiation of Th precursor cells into effector cells. Initial high-level IL-2 production is followed by its decline, and the concomitant induction of cytokines that are typical of the differentiated state. Although the factors that are responsible for the early induction of IL-2 are well defined, the mechanisms that are responsible for its down-regulation in later stages of Th development have not been studied as much. Previous work from our laboratory revealed a repressor function for the T-box transcription factor, T-bet, in IL-2 gene transcription. Here, we report that T-bet(S508) is required for the optimal repression of IL-2 production in developing Th1 cells. Phosphorylation of T-bet(S508) by casein kinase I and glycogen synthase kinase-3 kinases accompanies T-bet's interaction with the RelA nuclear factor-kappa B transcription factor. Heterodimerization of T-bet and RelA interferes with the binding of RelA to the IL-2 promoter, and hence, transcriptional activation of the IL-2 gene by RelA.
引用
收藏
页码:1289 / 1300
页数:12
相关论文
共 77 条
[21]   Negative cross-talk between the human orphan nuclear receptor Nur77/NAK-1/TR3 and nuclear factor-κB [J].
Harant, H ;
Lindley, IJD .
NUCLEIC ACIDS RESEARCH, 2004, 32 (17) :5280-5290
[22]   Signal transduction in development: Holding the key [J].
Harwood, AJ .
DEVELOPMENTAL CELL, 2002, 2 (04) :384-385
[23]   Direct transfer of p65 into T lymphocytes from systemic lupus erythematosus patients leads to increased levels of interleukin-2 promoter activity [J].
Herndon, TM ;
Juang, YT ;
Solomou, EE ;
Rothwell, SW ;
Gourley, MF ;
Tsokos, GC .
CLINICAL IMMUNOLOGY, 2002, 103 (02) :145-153
[24]   High mobility group protein I(Y) is required for function and for c-Rel binding to CD28 response elements within the GM-CSF and IL-2 promoters [J].
Himes, SR ;
Coles, LS ;
Reeves, R ;
Shannon, MF .
IMMUNITY, 1996, 5 (05) :479-489
[25]   Molecular mechanism of suppression of testicular steroidogenesis by proinflammatory cytokine tumor necrosis factor alpha [J].
Hong, CY ;
Park, JH ;
Ahn, RS ;
Im, SY ;
Choi, HS ;
Soh, J ;
Mellon, SH ;
Lee, K .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (07) :2593-2604
[26]   T helper cell fate specified by kinase-mediated interaction of T-bet with GATA-3 [J].
Hwang, ES ;
Szabo, SJ ;
Schwartzberg, PL ;
Glimcher, LH .
SCIENCE, 2005, 307 (5708) :430-433
[27]   TRANSCRIPTIONAL REGULATION OF THE IL-2 GENE [J].
JAIN, J ;
LOH, C ;
RAO, A .
CURRENT OPINION IN IMMUNOLOGY, 1995, 7 (03) :333-342
[28]   Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV [J].
Juang, YT ;
Wang, Y ;
Solomou, EE ;
Li, YS ;
Mawrin, C ;
Tenbrock, K ;
Kyttaris, VC ;
Tsokos, C .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (04) :996-1005
[29]   T-bet controls autoaggressive CD8 lymphocyte responses in type I diabetes [J].
Juedes, AE ;
Rodrigo, E ;
Togher, L ;
Glimcher, LH ;
von Herrath, MG .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (08) :1153-1162
[30]   Temporal and subunit-specific modulations of the Rel/NF-kappa B transcription factors through CD28 costimulation [J].
KahnPerles, B ;
Lipcey, C ;
Lecine, P ;
Olive, D ;
Imbert, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (35) :21774-21783